Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Tax Provisions (2016 - 2025)

Lipocine (LPCN) has disclosed Tax Provisions for 12 consecutive years, with $200.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Tax Provisions changed 0.0% year-over-year to $200.0, compared with a TTM value of $200.0 through Sep 2025, down 83.82%, and an annual FY2024 reading of $681.0, down 9.8% over the prior year.
  • Tax Provisions was $200.0 for Q1 2025 at Lipocine, down from $481.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $555.0 in Q4 2023 and bottomed at $200.0 in Q1 2021.
  • Average Tax Provisions over 5 years is $314.62, with a median of $200.0 recorded in 2021.
  • The sharpest move saw Tax Provisions changed 0.0% in 2021, then rose 15.38% in 2023.
  • Year by year, Tax Provisions stood at $200.0 in 2021, then surged by 140.5% to $481.0 in 2022, then increased by 15.38% to $555.0 in 2023, then dropped by 13.33% to $481.0 in 2024, then plummeted by 58.42% to $200.0 in 2025.
  • Business Quant data shows Tax Provisions for LPCN at $200.0 in Q1 2025, $481.0 in Q2 2024, and $200.0 in Q1 2024.